Market Tracker

08/18 5:16pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

3.56
Delayed Data
As of 4:00pm ET
 -0.09 / -2.47%
Today’s Change
3.18
Today|||52-Week Range
10.98
-17.40%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close3.65
Today’s open3.59
Day’s range3.54 - 3.65
Volume169,814
Average volume (3 months)279,454
Market cap$184.5M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+59.66%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.14+3.69%
ARWRArrowhead Pharmaceut...+0.11+5.47%
CDXSCodexis Inc+0.15+2.83%
BCLIBrainstorm Cell Ther...+0.02+0.48%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts